Pages that link to "Q44684238"

The following pages link to Differential effects of typical and atypical neuroleptics on mitochondrial function in vitro (Q44684238):

Displaying 28 items.

• Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis (Q28550401) (← links)
• Mitochondrion-toxic drugs given to patients with mitochondrial psychoses (Q28710444) (← links)
• Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection (Q30386608) (← links)
• Gene networks and haloperidol-induced catalepsy. (Q30409648) (← links)
• Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging (Q30600526) (← links)
• Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research (Q30995022) (← links)
• Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects (Q33503890) (← links)
• Characterization of the type 2 NADH:menaquinone oxidoreductases from Staphylococcus aureus and the bactericidal action of phenothiazines (Q33717526) (← links)
• Risperidone-Induced Renal Damage and Metabolic Side Effects: The Protective Effect of Resveratrol (Q33863719) (← links)
• Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia (Q34137363) (← links)
• Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. (Q37072337) (← links)
• Clinical response of quetiapine in rapid cycling manic bipolar patients and lactate level changes in proton magnetic resonance spectroscopy (Q37318145) (← links)
• Drugs interfering with mitochondrial disorders (Q37617357) (← links)
• Connectivity between mitochondrial functions and psychiatric disorders (Q37854101) (← links)
• The mitochondrial genome and psychiatric illness (Q38034189) (← links)
• Proteome and pathway effects of chronic haloperidol treatment in mouse hippocampus. (Q38399332) (← links)
• Cross-reactivity of Antibodies Directed to the Gram-Negative Bacterium Neisseria gonorrhoeae With Heat Shock Protein 60 and ATP-Binding Protein Correlates to Reduced Mitochondrial Activity in HIBCPP Choroid Plexus Papilloma Cells (Q38863427) (← links)
• Development of a no-wash assay for mitochondrial membrane potential using the styryl dye DASPEI. (Q42936035) (← links)
• In vitro/vivo studies towards mechanisms of risperidone-induced oxidative stress and the protective role of coenzyme Q10 and N-acetylcysteine. (Q46465683) (← links)
• Mitochondrial Dysfunction in Schizophrenia: Determination of Mitochondrial Respiratory Activity in a Two-Hit Mouse Model (Q50534987) (← links)
• Psychotropic medications and mitochondrial toxicity (Q50748369) (← links)
• Mitochondrial Complex I Deficiency in Schizophrenia and Bipolar Disorder and Medication Influence. (Q52338574) (← links)
• Efflux Pumps in Mycobacteria: Antimicrobial Resistance, Physiological Functions, and Role in Pathogenicity (Q57656351) (← links)
• Mitochondrial DNA copy number is associated with psychosis severity and anti-psychotic treatment (Q58707676) (← links)
• Assessment of drug-induced mitochondrial dysfunction via altered cellular respiration and acidification measured in a 96-well platform (Q84357212) (← links)
• Amygdalohippocampal neuroplastic changes following neuroleptic treatment with quetiapine in first-episode schizophrenia (Q87095474) (← links)
• Safety of drug use in patients with a primary mitochondrial disease: An international Delphi-based consensus (Q89587800) (← links)
• Systems Analysis of the 22q11.2 Microdeletion Syndrome Converges on a Mitochondrial Interactome Necessary for Synapse Function and Behavior (Q92127596) (← links)